Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics
The absence of herd immunity to orthopoxviruses and the concern that variola or monkeypox viruses could be used for bioterroristic activities has stimulated the development of therapeutics and safer prophylactics. One major limitation in this process is the lack of accessible human orthopoxvirus inf...
Main Authors: | R. Mark Buller, Jill Schriewer, George Painter, Akbar M. Siddiqui, Scott Parker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/2/9/1918/ |
Similar Items
-
Development of CMX001 for the Treatment of Poxvirus Infections
by: George Painter, et al.
Published: (2010-12-01) -
The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
by: Scott A. Foster, et al.
Published: (2017-10-01) -
Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
by: Richard W. Moyer, et al.
Published: (2011-01-01) -
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
by: Scott Foster, et al.
Published: (2011-01-01) -
T cell cytokine synthesis at the single-cell level in BALB/c and C57BL/6 mice infected with ectromelia virus
by: Lidia Szulc, et al.
Published: (2012-04-01)